Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors

✍ Scribed by Adam S. Levy; Paul A. Meyers; Leonard H. Wexler; Regina Jakacki; Anne Angiolillo; Sarah N. Ringuette; Marvin B. Cohen; Richard Gorlick; Other site principal investigators: Wayne Furman; MD (St. Jude Children's Research Hospital; Memphis; Tennessee); Rochelle Bagatell; MD (University of Arizona Health Sciences Center; Tucson; Arizona); Lori Luchtman-Jones; MD (Washington University School of Medicine; St. Louis; Missouri); Luis Eduardo Garcia; MD (Hospital CIMA; San Jose; Costa Rica);; Eric Sandler; MD (Nemours Children's Clinic; Jacksonville; Florida).

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 174 KB
• Volume: 115
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.23992